Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2a versus conventional care in hepatitis C cirrhosis
2004-000417-18Phase 3Completed
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- May 2008
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of interferon alfa in hepatitis C virus infection and Cirrhosis (2 arms), sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: Combined primary endpoint. Started May 2008; status: completed.
02
Drugs
interferon alfa
03
Conditions
hepatitis C virus infectionCirrhosis
Beyond the preview
Go deeper on 2004-000417-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000417-18.